Introduced under the systematic designation 4-Thiazolecarboxylic Acid, 2-[[(1,1-Dimethylethoxy)Carbonyl]Amino]- (IUPAC: 2-{[(tert-butoxy)carbonyl]amino}-1,3-thiazole-4-carboxylic acid), the compound is supplied as a white to off-white crystalline powder with a molar mass of 244.27 g·mol⁻¹ and a molecular formula of C₉H₁₂N₂O₄S. The protecting group strategy—anchoring the exocyclic amine via a tert-butoxycarbonyl (Boc) function—defines its stability profile and synthetic utility across multi-step heterocyclic construction. Typical lot analysis records a thermal transition within the interval 198–203°C accompanied by decomposition, a chromatographic purity floor of ≥98.5% by reversed-phase HPLC (220 nm detection), and a residual water content held below 0.50% w/w via pre-dispatching vacuum drying. The product is dispatched with a Certificate of Analysis referencing European Pharmacopoeia monograph 2.2.28 for related substances and validated against the current quality system standard ISO 9001:2015.
What limits shelf life under tropical storage conditions?
Stability studies conducted at 40°C/75% RH in accordance with ICH Q1A(R2) demonstrate that the primary degradation pathway is acid-catalyzed deprotection of the Boc carbamate, yielding 2-aminothiazole-4-carboxylic acid as the dominant degraded species. When the packaging headspace oxygen is controlled below 5.0% v/v and the desiccant load is sized for a moisture vapor transmission rate not exceeding 0.015 g·m⁻²·day⁻¹, the assigned retest date extends to 36 months for product stored at 2–8°C. Temporary excursions into ambient temperatures (≤30°C) during transport do not induce a purity shift exceeding 0.3% area-normalized provided the cumulative thermal stress remains below 120 degree-hours above 25°C. Multiple freeze-thaw cycles across −20°C to 25°C, however, accelerate hydration of the thiazole ring at the C-2 position when the powder is handled in open vessels at relative humidity above 60%; therefore, single-use aliquotting under inert gas is recommended for laboratories operating in subtropical zones with diurnal condensation risk.
Injection molding of thermoplastics is absent from this compound’s profile. Instead, the downstream processing bottleneck that manufacturers of active pharmaceutical ingredients encounter occurs at the scale-up of the amide coupling step where the free acid is activated. On campaigns exceeding 50 kg batch size, the exotherm associated with in situ generation of the acid chloride using thionyl chloride in tetrahydrofuran must be managed by jacket cooling capable of absorbing 85 kJ·min⁻¹ at peak evolution. Rushing the addition rate beyond 0.45 molar equivalents·min⁻¹ has been linked to localized hot spots that cause premature Boc cleavage, generating the nucleophilic free amine that subsequently forms homodimers and reduces the yield of the desired amide to below 72% of theoretical. Plant operators employ cascaded progressive cavity pumps calibrated to a feed accuracy of ±1.5% of setpoint to maintain the addition profile within safe boundaries.
Chromatographic Purity Assessment: HPLC Method Alignment with General Chapter 2.2.29
Routine lot release relies on a gradient HPLC method employing a C18 stationary phase (dimensions 250 mm × 4.6 mm, particle size 5 μm) and a mobile phase composed of 0.1% trifluoroacetic acid in water and acetonitrile. The gradient is programmed from 10% to 90% organic modifier over 25 minutes at a flow rate of 1.0 mL·min⁻¹. Detection at 220 nm captures the thiazole chromophore with a limit of quantitation for the unprotected 2-amino analog confirmed at 0.05 μg·mL⁻¹. Relative retention times for the des-Boc derivative and the thiazole ring-opened impurity are compiled with system suitability criteria requiring resolution ≥2.0 between the critical pair and a tailing factor ≤1.5 for the principal peak. Laboratories auditing the method against ICH Q2(R1) are provided with a validated linearity range spanning 0.05–150% of the nominal sample concentration, and intermediate precision data showing an RSD ≤1.8% across six independent preparations.
An orthogonal 1H NMR assay (DMSO-d₆, 400 MHz) is employed as identity confirmation, with diagnostic signals corresponding to the tert-butyl singlet at 1.43 ppm (9H) and the thiazole C-5 proton at 8.12 ppm. Residual solvent analysis by headspace GC per USP ⟨467⟩ is performed when the product is ordered for GMP-regulated intermediate steps; limits for tetrahydrofuran and dichloromethane are set at 720 ppm and 600 ppm, respectively.
A case where the unprotected analog leads to dithiazole dimer formation
Direct comparison with 2-aminothiazole-4-carboxylic acid (CAS 4021-08-4) reveals a critical divergence in oxidative coupling behavior. Under the mildly basic conditions required for peptide bond formation with carbodiimide activators, the free amine undergoes aerobic head-to-tail dimerization to generate 2,2′-azanediyldi(thiazole-4-carboxylic acid) within 4–6 hours at ambient temperature. The dimer concentration can exceed 11% by area in the crude reaction mixture when the pH is maintained between 7.5 and 8.2, necessitating an additional crystallization step that reduces overall yield by 18–22%. The Boc-protected derivative suppresses this pathway entirely; even after 24 hours of stirring in N,N-dimethylformamide at 25°C in the presence of 1.05 equivalents of N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride, dimer content remains below the reporting threshold of 0.10%. This disparity is the primary selection criterion when the thiazole scaffold must survive multiple synthetic operations before the amine is unveiled for final elaboration.
| Protecting group | Cleavage reagent system | Reaction temperature (°C) | Half-life observed (min) | Co-solvent compatibility |
|---|---|---|---|---|
| Boc | 4 M HCl in 1,4-dioxane or TFA/CH₂Cl₂ (1:1) | 20–25 | 12–15 | Alkanes, esters, ethers |
| Fmoc | 20% piperidine in DMF | 20–25 | 8–10 | Avoid chlorinated solvents (dibenzofulvene adduct precipitation) |
| Cbz | H₂ (1 atm), 10% Pd/C, EtOAc | 20–25 | 45–60 | Thioethers and thiophenes may poison catalyst |
The selection of Boc over Fmoc becomes mandatory when the subsequent coupling partner contains base-labile functionality such as a methyl ester or a β-lactam ring. In the kilogram-scale synthesis of a factor Xa inhibitor intermediate structurally related to edoxaban, process engineers reported that exposing the Fmoc-protected precursor to the piperidine-DMF deblocking cocktail caused transesterification of the adjacent ethyl carboxylate at 5–7% conversion after 25 minutes, complicating purification. The Boc variant, activated with anhydrous hydrogen chloride in ethyl acetate, afforded the hydrochloride salt of the free amine in 94% isolated yield without detectable ester hydrolysis. Consequently, the compound described here is positioned as the preferred building block for medicinal chemistry programs where an acid-labile protecting group aligns with the global synthetic strategy.
Specifications conform to REACH Article 20 registration requirements for the intermediate use category. The product is not classified as dangerous under Regulation (EC) No 1272/2008 in neat form; however, upon thermal decomposition above 230°C, evolution of oxides of sulfur and isobutylene necessitates local exhaust ventilation in process areas. Bulk shipments for GMP manufacturing are accompanied by a FDA 21 CFR Part 211 compliance statement, a supplier qualification questionnaire aligned with EXCiPACT annex for pharmaceutical auxiliaries, and a stability-indicating method transfer package.
When residual acetic acid at the ppm level shifts impurity profiles
Trace acetic acid carried over from the final recrystallization step, if not reduced below 50 ppm by a forced-air drying ramp ending at 45°C, accelerates the formation of the N-acetyl-2-aminothiazole-4-carboxylic acid impurity under long-term storage. Stability lots stored for 24 months at 25°C/60% RH showed that an initial acetic acid concentration of 120 ppm correlated with an N-acetyl impurity level reaching 1.8% area, exceeding the pharmacopoeial identification threshold of 1.0%. Manufacturers are therefore advised to request an ion chromatography report (Dionex ICS-6000, conductivity detector) documenting acetate content rather than relying solely on the gravimetric loss-on-drying value. This requirement is communicated in the technical datasheet as supplementary information SI-6.
Documentation for customs clearance and regulatory submission includes the Harmonised System code 2934.10, an elemental impurities risk assessment per ICH Q3D (Class 1 metals collectively <0.5 μg·g⁻¹), and a certified statement that no substances of animal origin are employed in the synthetic pathway (TSE/BSE compliance per EMA/410/01 Rev.3). Supply chain audit reports archived under ISO 28000:2022 provide chain-of-custody verification for shipments transiting bonded warehouses in Southeast Asian logistics hubs.
